Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice
暂无分享,去创建一个
H. Rugo | A. DeMichele | R. Finn | M. Cristofanilli | A. Brufsky | B. Emir | M. Torres | J. Mardekian | R. Layman | Xianchen Liu | L. McRoy